Fsb Premier Wealth Management, Inc.
Source: SEC Form 13F · as of Mar 2026Fsb Premier Wealth Management, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $18.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$18.0M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 28,304 | $4.7M |
| NVSNovartis AG | 16,970 | $2.6M |
| MCKMcKesson Corporation | 2,494 | $2.2M |
| SNYSanofi | 28,831 | $1.4M |
| ELVElevance Health Inc. | 4,605 | $1.3M |
| JNJJOHNSON & JOHNSON | 3,804 | $930K |
| AMGNAMGEN INC | 2,262 | $796K |
| IQVIQVIA Holdings Inc. | 4,395 | $750K |
| CORCencora Inc. | 1,807 | $568K |
| ABBVAbbVie Inc. | 1,920 | $418K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,464 | $396K |
| BMYBRISTOL MYERS SQUIBB CO | 6,438 | $390K |
| PFEPFIZER INC | 10,751 | $302K |
| LLYELI LILLY & Co | 326 | $300K |
| MRKMerck & Co., Inc. | 2,288 | $275K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,461 | $246K |
| AZNASTRAZENECA PLC | 1,192 | $235K |
| ABTABBOTT LABORATORIES | 1,979 | $203K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.